Receiving enzyme replacement therapy for a lysosomal storage disorder: A preliminary exploration of the experiences of young patients and their families

Journal of Genetic Counseling

Volumn 22, Issue 4, 2013, Pages 517-532

  Freedman, R ^a   Sahhar, M ^a,b   Curnow, L ^b   Lee, J ^b,c   Peters, H ^b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Genetic Health Services Victoria   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Biopsychosocial model; Enzyme replacement therapy; Families; Gaucher; Health related quality of life; Lysosomal storage disorder; Mucopolysaccharidosis; Pompe; Young people

Indexed keywords

ADULT; ARTICLE; ENZYME REPLACEMENT; FEMALE; HUMAN; LYSOSOME STORAGE DISEASE; MALE; PATHOPHYSIOLOGY; QUALITY OF LIFE; YOUNG ADULT; LYSOSOMAL STORAGE DISEASES;

ADULT; ENZYME REPLACEMENT THERAPY; FEMALE; HUMANS; LYSOSOMAL STORAGE DISEASES; MALE; QUALITY OF LIFE; YOUNG ADULT;

EID: 84879950615     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9579-1     Document Type: Article

References (60)

1. Australian Government Department on Health and Ageing (2010a). The review of the life saving drugs program. Retrieved from http://www.health.gov.au/ internet/main/publishing.nsf/Content/lsdpinfo/$File/LSDPreview.pdf.
2. Australian Government Department on Health and Ageing (2010b). Guidelines for the treatment of mucopolysaccharidosis type I (MPSI) disease through the life saving drugs program. Retrieved from http://www.health.gov.au/internet/ main/publishing.nsf/content/lsdp-info#Laronidase.
3. Australian Government Department on Health and Ageing (2010c). Guidelines for the treatment of mucopolysaccharidosis type II(MPSII) disease through the life saving drugs program. Retrieved from http://www.health.gov.au/internet/ main/publishing.nsf/content/lsdp-info#Idursulfase.
4. Australian Government Department on Health and Ageing (2010d). Guidelines for eligibility to receive treatment of infantile-onset Pompe disease through the life saving drugs program. http://www.health.gov.au/internet/main/ publishing.nsf/content/lsdp-info#Alglucosidase.
5. Australian Government Department on Health and Ageing (2010e). Guidelines for the treatment of gaucher disease through the life saving drugs program. Retrieved from http://www.health.gov.au/internet/main/publishing.nsf/content/ lsdp-info#Imiglucerase.
6. Australian Government National Health and Medical Research Council, Australian Research Council, & Australian Vice-Chancellors Committee (2007). National statement on ethical conduct in human research.
7. Bailey, L. (2008). An overview of enzyme replacement therapy for lysosomal storage diseases. The Online Journal of Nursing, 13(1), man3. Retrieved from www.nursingworld.org/mainmenucategories/anamarketplace/ anaperiodicals.
8. Barker, J.; Weller, S. (2003). "Is it fun?" Developing children centred research methods. International Journal of Sociology and Social Policy, 22(1/2), 33-58.
9. Barlow, J. H.; Ellard, D. R. (2006). The psychosocial well-being of children with chronic disease, their parents and siblings: an overview of the research evidence base. Child: Care, Health and Development, 32(1), 19-31.
10. Beck, M. (2007). New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Human Genetics, 121(1), 1-22.
11. Brady, R.; Schiffmann, R. (2004). Enzyme replacement therapy for metabolic storage disorders. The Lancet-Neurology, 3(12), 752-756.
12. Braun, V.; Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101.
13. Burton, B. K.; Wiesman, C.; Paras, A.; Kim, K.; Katz, R. (2009). Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses. Molecular Genetics and Metabolism, 97(3), 234-236.
14. Clarke, L. A.; Heppner, J. (2011). Mucopolysaccharidosis type I. Retrieved from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part= mps1.
15. Coman, D.; Hayes, I.; Collins, V.; Sahhar, M.; Wraith, J.; Delatycki, M. (2008). Enzyme replacement therapy for mucopolysacharidoses: opinions of patients and families. Journal of Pediatrics, 152(5), 723-727.
16. Coyne, I. (2006). Consultation with children in hospital: children, parents' and nurses' perspectives. Journal of Clinical Nursing, 15(1), 61-71.
17. Deegan, P. B.; Cox, T. M. (2009). In D. Warrell, S. Firth, & T. Cox (Eds.), Lysosmal disease: Selected material from the Oxford textbook of medicine (5th ed.). New York: Oxford University Press.
18. Dickinson, A. R.; Smythe, E.; Spence, D. (2006). Within the web: the family-practitioner relationship in context of chronic child illness. Journal of Child Health Care, 10(4), 309-325.
19. Drew, S. E.; Duncan, R. E.; Sawyer, S. M. (2010). Visual storytelling: a beneficial but challenging method for health research with young people. Qualitative Health Research, 20(12), 1677-1688.
20. Driessnack, M. (2006). Draw-and-tell conversations with children about fear. Qualitative Health Research, 16(10), 1414-1435.
21. Epstein, I.; Stevens, B.; McKeever, P.; Baruchel, S. (2006). Photo elicitation interview, using photos to elicit children's perspectives. International Journal of Qualitative Methods, 5(3), 1-9.
22. Evans, C. (2006). Genetic counselling a psychological approach. Cambridge: Cambridge University Press.
23. Giarelli, E.; Bernhardt, B. A.; Mack, R.; Pyeritz, R. E. (2008). Adolescents' transition to self-management of a chronic genetic disorder. Qualitative Health Research, 18(4), 441-457.
24. Hartley, J. N.; Greenberg, C. R.; Mhanni, A. A. (2011). Genetic counseling in a busy paediatric metabolic practice. Journal of Genetic Counseling, 20(1), 20-22.
25. Horstman, M.; Aldiss, S.; Richardson, A.; Gibson, F. (2008). Methodological issues when using the draw and write technique with children aged 6 to 12 years. Qualitative Health Research, 18(7), 1001-1011.
26. Huffman, K.; Vernoy, M.; Vernoy, J. (2000). Psychology in action (5th ed.). New York: John Wiley & Sons.
27. Hughes, D. A.; Milligan, A.; Mehta, A. (2007). Home therapy for lysosomal storage disorders. British Journal of Nursing, 16(22), 1384-1389.
28. Kessler, S. (1997). Psychosocial aspects of genetic counselling: X advanced counselling techniques. Journal of Genetic Counselling, 6(4), 380-392.
29. Levy-Lahad, E.; Zimran, A. (1997). Gaucher's disease: genetic counseling and population screening. Baillere's Clinical Haematology, 10(4), 779-792.
30. Mack, R.; Giarelli, E.; Bernhardt, B. A. (2009). The adolescent research participant: strategies for productive and ethical interviewing. Journal of Pediatric Nursing, 24(6), 448-457.
31. Martins, A. M.; Dualibi, A. P.; Norato, D.; Takata, E. T.; Santos, E. S.; Valaders, et al. (2009). Guidelines for the management of mucopolysaccharidosis type 1. Journal of Pediatrics, 155(4 suppl 2), S32-46.
32. McDougall, J.; Horgan, K.; Baldwin, P.; Tucker, M.; Frid, P. (2008). Employing the international classification of functioning, disability and health to enhance the services for children and youth with chronic physical health conditions and disabilities. Paediatric Child Health, 13(3), 173-178.
33. Meikle, P. J.; Hopwood, J. J. (2003). Lysosomal disorders: emerging therapeutic options required early diagnosis. European Journal of Pediatrics, 162(1Suppl), s34-s37.
34. Metcalfe, A.; Plumridge, G.; Coad, J.; Shanks, A.; Gill, P. (2011). Parents' and children's communication about genetic risk: a qualitative study, learning from families' experiences. European Journal of Human Genetics, 19(6), 640-646.
35. Muenzer, J. (2004). The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. Journal of Pediatrics, 144(5 Suppl), s27-s34.
36. Nærde, A.; Tambs, K.; Mathiesen, K. S.; Dalgard, O. S.; Samuelsen, S. O. (2000). Symptoms of anxiety and depression among mothers of pre-school children: effect of chronic strain related to children and child care-taking. Journal of Affective Disorders, 58(3), 181-199.
37. O'Brien, I.; Duffy, A.; Nicholl, H. (2009). Impact of childhood chronic illness on siblings: a literature review. British Journal of Nursing, 18(22), 1358-1364.
38. Packman, W.; Crosbie, T. W.; Behnken, M.; Eudy, K.; Packman, S. (2010). Living with Gaucher disease: emotional health, psychosocial needs and concerns of individuals with Gaucher disease. American Journal of Medical Genetics. Part A, 152A(8), 2002-2010.
39. Pastores, M.; Hughes, D. (2008). Gaucher disease. Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK1269/.
40. Pitt, C.; Lavery, C.; Wager, N. (2009). Psychosocial outcomes of bone marrow transplant for individuals affected by mucopolysaccharidosis I hurler disease: patient social competency. Child: Care, Health and Development, 35(2), 271-280.
41. Reeves, E.; Timmons, S.; Dampier, S. (2006). Parents experience of negotiating care for their technology - dependent child. Journal of Child Health Care, 10(3), 228-238.
42. Scarpa, M. (2011). Mucopolysaccharidosis type II. Retrieved from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter.
43. Schulze-Frenking, G.; Jones, S. A.; Roberts, J.; Beck, M.; Wraith, J. E. (2011). Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II. Journal of Inherited Metabolic Disease, 34(1), 203-208.
44. Sharpe, D.; Rossiter, L. (2002). Siblings of children with a chronic illness: a meta-analysis. Journal of Peadiatric Psychology, 27(8), 699-710.
45. Sifuentes, M.; Doroshow, R.; Hoft, R.; Mason, G.; Walot, I.; Diament, M.; et al. (2007). A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Molecular Genetics and Metabolism, 90(2), 171-180.
46. Spieth, L.; Harris, E. (1996). Assessment of health related quality of life in children and adolescents: an integrative review. Journal of Paediatric Psychology, 21(2), 175-193.
47. Starks, H.; Brown Trinidad, S. (2007). Choose your method: a comparison of phenomenology, discourse analysis and grounded theory. Qualitative Health Research, 17(10), 1372-1380.
48. Sternberg, R. (1998). In search of the human mind. Fortworth: Harcourt Brace.
49. Stewart, J. L.; Mishel, M. H. (2000). Uncertainty in childhood illness: a synthesis of the parent and child literature. Scholarly Inquiry for Nursing Practice, 14(4), 299-319.
50. Tadema, A. C.; Vlaskamp, C. (2009). The time and effort in taking care for children with profound intellectual and multiple disabilities: a study on care load and support. British Journal of Learning Disabilities, 38(1), 41-48.
51. Taylor, R. M.; Gibson, F.; Franck, L. S. (2008). A concept analysis of health-related quality of life in young people with chronic illness. Journal of Clinical Nursing, 17(14), 1823-1833.
52. Taylor, R. M.; Franck, L. S.; Dhawan, A.; Gibson, F. (2010). The stories of young people living with a liver transplant. Qualitative Health Research, 20(8), 1076-1090.
53. Tinkle, B.; Leslie, N. (2010). Glycogen storage disease type II (Pompe Disease). Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK1261.
54. Van Der Beek, N. A. M. E.; Hagemans, M. L. C.; Van Der Ploeg, A. T.; Reuser, A. J. J.; Van Doorn, P. A. (2006). Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. Acta Neurologica Belgica, 106(2), 82-86.
55. Waisbren, S.; Rones, M.; Read, C. Y.; Marsden, D.; Levy, H. L. (2004). Brief report: predictors of parenting stress among parents of children with biochemical genetic disorders. Journal of Pediatric Psychology, 29(7), 565-570.
56. Wilcox, W. R. (2004). Lysosomal storage disorders: the need for better paediatric recognition and comprehensive care. Journal of Paediatrics, 144(suppl), s3-s14.
57. World Health Organisation (2002). Towards a common language for functioning, disability and health: ICF The International Classification of Functioning, Disability and Health. Retrieved from http://www.who.int/ classifications/icf/training/icfbeginnersguide.pdf.
58. Wraith, J. E.; Scarpa, M.; Beck, M.; Bodamer, O. A.; De Meirleir, L.; Guffon, N.; et al. (2008). Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics, 167(3), 267-277.
59. Wynn, R. F.; Mercer, J.; Page, J.; Carr, T. F.; Jones, S.; Wraith, J. E. (2009). Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis i: experience in 18 Patients. The Journal of Pediatrics, 154(1), 135-139.
60. Zierhut, H. A, & Bartels, D. M. (2012). Waiting for the next shoe to drop: the experience of parents of children with fanconi anemia. Journal of Genetic Counseling. Retrieved from http://www.springerlink.com.ezp.lib.unimelb. edu.au/content/1059-7700/?k=shoe+to+drop.